| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jennings GK et al. | Spin equilibrium and Oâ‚‚-binding kinetics of Mycobacterium tuberculosis CYP51 with mutations in the histidine-threonine dyad. | 2014 | J. Inorg. Biochem. | pmid:24793591 |
| Sukhanova A et al. | Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. | 2013 | Cancer Discov | pmid:23125191 |
| Keber R et al. | Male germ cell-specific knockout of cholesterogenic cytochrome P450 lanosterol 14α-demethylase (Cyp51). | 2013 | J. Lipid Res. | pmid:23509403 |
| Keber R et al. | Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14alpha-demethylase (Cyp51) resembles Antley-Bixler syndrome. | 2011 | J. Biol. Chem. | pmid:21705796 |
| AÄimoviÄ J et al. | Circadian rhythm of cholesterol synthesis in mouse liver: a statistical analysis of the post-squalene metabolites in wild-type and Crem-knock-out mice. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21531203 |
| Liu XT et al. | Antibacterial compounds from mushrooms I: a lanostane-type triterpene and prenylphenol derivatives from Jahnoporus hirtus and Albatrellus flettii and their activities against Bacillus cereus and Enterococcus faecalis. | 2010 | Planta Med. | pmid:19644795 |
| Zhu J et al. | Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptake. | 2010 | J. Lipid Res. | pmid:20037138 |
| Warrilow AG et al. | Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B. | 2010 | Antimicrob. Agents Chemother. | pmid:20660663 |
| Chen CK et al. | Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit. | 2009 | PLoS Negl Trop Dis | pmid:19190730 |
| Lange Y et al. | Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. | 2008 | J. Biol. Chem. | pmid:18024962 |
| Sood R and Kinnunen PK | Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L. | 2008 | Biochim. Biophys. Acta | pmid:18358828 |
| Nguyen AD et al. | Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of insigs. | 2007 | J. Biol. Chem. | pmid:17635920 |
| Buurman ET et al. | Utilization of target-specific, hypersensitive strains of Saccharomyces cerevisiae to determine the mode of action of antifungal compounds. | 2005 | Antimicrob. Agents Chemother. | pmid:15917573 |
| Kavtaradze LK et al. | A low-toxicity method for the separation of lanosterol and dihydrolanosterol from commercial mixtures. | 2004 | Steroids | pmid:15465116 |
| Berger A et al. | Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. | 2004 | Lipids Health Dis | pmid:14969592 |
| Liu XY et al. | Creating new supramolecular materials by architecture of three-dimensional nanocrystal fiber networks. | 2002 | J. Am. Chem. Soc. | pmid:12475350 |
| Sonoda Y et al. | Purification of a human cytochrome P-450 isozyme catalyzing lanosterol 14 alpha-demethylation. | 1993 | Biochim. Biophys. Acta | pmid:8399332 |
| Aoyama Y et al. | Structural analysis of the interaction between the side-chain of substrates and the active site of lanosterol 14 alpha-demethylase (P-450(14)DM) of yeast. | 1992 | Biochim. Biophys. Acta | pmid:1504086 |
| Aoyama Y and Yoshida Y | Different substrate specificities of lanosterol 14a-demethylase (P-45014DM) of Saccharomyces cerevisiae and rat liver for 24-methylene-24,25-dihydrolanosterol and 24,25-dihydrolanosterol. | 1991 | Biochem. Biophys. Res. Commun. | pmid:1872829 |
| Nes WD et al. | Concerning the role of 24,25-dihydrolanosterol and lanostanol in sterol biosynthesis by cultured cells. | 1989 Mar-May | Steroids | pmid:2799854 |
24,25-dihydrolanosterol
24,25-dihydrolanosterol is a lipid of Sterol Lipids (ST) class. The involved functions are known as Binding (Molecular Function), Force, Molecular Dynamics and Synthesis. The related lipids are Sterols and Steroids.
Cross Reference
Introduction
To understand associated biological information of 24,25-dihydrolanosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 24,25-dihydrolanosterol?
There are no associated biomedical information in the current reference collection.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with 24,25-dihydrolanosterol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 24,25-dihydrolanosterol?
There are no associated biomedical information in the current reference collection.
What functions are associated with 24,25-dihydrolanosterol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 24,25-dihydrolanosterol?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 24,25-dihydrolanosterol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with 24,25-dihydrolanosterol?
There are no associated biomedical information in the current reference collection.